Intradiscal drug delivery system for the treatment of low back pain

Journal of Biomedical Materials Research - Part A

Volumn 92, Issue 1, 2010, Pages 378-385

  Lee, Jin Whan ^a   Lim, Tae Hong ^a   Park, Joon B ^a  

^a Bisco Inc   (United States)

Author keywords

Disc; Drug delivery; Hydrogel; Low back pain

Indexed keywords

BODY TEMPERATURE; BUPIVACAINE; DISC; DRUG CARRIER; DRUG DELIVERY SYSTEM; HYDROGEL MATRIX; IN-SITU FORMING; IN-VITRO TESTS; LOW BACK PAIN; MODEL DRUGS; PLURONIC F-127; POSSIBLE SOLUTIONS; ROOM TEMPERATURE; SODIUM HYALURONATE; SUSTAINED RELEASE;

DRUG DELIVERY; PHASE TRANSITIONS; SODIUM;

HYDROGELS;

BUPIVACAINE; HYALURONIC ACID; MICROSPHERE;

ARTICLE; BODY TEMPERATURE; CADAVER; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; GELATION; HYDROGEL; LOW BACK PAIN; MATHEMATICAL MODEL; NONHUMAN; PHASE TRANSITION; ROOM TEMPERATURE; TEMPERATURE MEASUREMENT; VISCOSITY;

ANIMALS; BUPIVACAINE; CATTLE; DRUG DELIVERY SYSTEMS; HYALURONIC ACID; HYDROGEL; INJECTIONS, SPINAL; LOW BACK PAIN; LUMBAR VERTEBRAE; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; MOLECULAR WEIGHT; POLOXAMER; SOLVENTS; TEMPERATURE; VISCOSITY;

EID: 73549088954     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32377     Document Type: Article

References (38)

1. Katz, JN. Lumbar disc disorders and low-back pain: Socioeconomic factors and consequences. J Bone Joint Surg Am 2006;88 (Suppl 2):21-24.
2. Lotz JC, Ulrich JA. Innervation, inflammation, and hypermobility may characterize pathologic disc degeneration: Review of animal model data. J Bone Joint Surg Am 2006;88 (Suppl 2):76-82.
3. Norcross JP, Lester GE, Weinhold P, Dahners LE. An in vivo model of degenerative disc disease. J Orthop Res 2003;21:183-188.
4. Freemont AJ, Watkins A, Le Maitre C, Jeziorska M, Hoyland JA. Current understanding of cellular and molecular events in intervertebral disc degeneration: Implications for therapy. J Pathol 2002;196:374-379.
5. Freemont AJ, Watkins A, Le Maitre C, Baird P, Jeziorska M, Knight MT, Ross ER, O'Brien JP, Hoyland JA. Nerve growth factor expression and innervation of the painful intervertebral disc. J Pathol 2002;197:286-292.
6. Le Maitre CL, Hoyland JA, Freemont AJ. Studies of human intervertebral disc cell function in a constrained in vitro tissue culture system. Spine 2004;29:1187-1195.
7. Brisby H. Pathology and possible mechanisms of nervous system response to disc degeneration. J Bone Joint Surg Am 2006;88 (Suppl 2):68-71.
8. Walsh AJ, Lotz JC. Biological response of the intervertebral disc to dynamic loading. J Biomech 2004;37:329-337.
9. Lotz JC. Animal models of intervertebral disc degeneration: Lessons learned. Spine 2004;29:2742-2750.
10. Lotz JC, Hsieh AH, Walsh AL, Palmer EI, Chin JR. The biology of the intervertebral disc. Biochem Soc Trans 2002;30:829-878.
11. Riesenburger RI, David CA. Lumbar microdiscectomy and microendoscopic discectomy. Minim Invasive Ther Allied Technol 2006;15:267-270.
12. Tay BB, Berven S. Indications, techniques, and complications of lumbar interbody fusion. Semin Neurol 2002;22:221-230.
13. Lee DY, Ahn Y, Lee SH. Percutaneous endoscopic lumbar discectomy for adolescent lumbar disc herniation: Surgical outcomes in 46 consecutive patients. Mt Sinai J Med 2006;73:864-870.
14. Isaacs RE, Podichetty VK, Santiago P, Sandhu FA, Spears J, Kelly K, Rice L, Fessler RG. Minimally invasive microendoscopy-assisted transforaminal lumbar interbody fusion with instrumentation. J Neurosurg Spine 2005;3:98-105.
15. Alander DH. Innovations in the treatment of low back pain. Mo Med 2005;102:225-229; quiz 229-230.
16. Hoogland T, Schubert M, Miklitz B, Ramirez A. Transforaminal posterolateral endoscopic discectomy with or without the combination of a low-dose chymopapain: A prospective randomized study in 280 consecutive cases. Spine 2006;31:E890-E897.
17. Fessler RG, O'Toole JE, Eichholz KM, Perez-Cruet MJ. The development of minimally invasive spine surgery. Neurosurg Clin N Am 2006;17:401-409.
18. Wallach CJ, Gilbertson LG, Kang JD. Gene therapy applications for intervertebral disc degeneration. Spine 2003;28:S93-S98.
19. Sobajima S, Shimer AL, Chadderdon RC, Kompel JF, Kim JS, Gilbertson LG, Kang JD. Quantitative analysis of gene expression in a rabbit model of intervertebral disc degeneration by real-time polymerase chain reaction. Spine J 2005;5:14-23.
20. Lin WJ, Huang LI. Influence of pluronics on protein-loaded poly(epsilon-caprolactone) microparticles. J Microencapsul 2001;18:191-197.
21. Lin WJ, Kang WW. Comparison of chitosan and gelatin coated microparticles: Prepared by hot-melt method. J Microencapsul 2003;20:169-177.
22. Aberturas MR, Molpeceres J, Guzman M, Garcia F. Development of a new cyclosporine formulation based on poly(caprolactone) microspheres. J Microencapsul 2002;19:61-72.
23. Bromberg L, Rashba-Step J, Scott T. Insulin particle formation in supersaturated aqueous solutions of poly(ethylene glycol). Biophys J 2005;89:3424-3433.
24. Owusu-Ababio G, Rogers JA. Formulation and release kinetics of cephalexin monohydrate from biodegradable polymeric microspheres. J Microencapsul 1996;13:195-205.
25. Igartua M, Hernandez RM, Esquisabel A, Gascon AR, Calvo MB, Pedraz JL. Influence of formulation variables on the in-vitro release of albumin from biodegradable microparticulate systems. J Microencapsul 1997;14:349-356.
26. Shu XZ, Liu Y, Palumbo F, Prestwich GD. Disulfide-cross-linked hyaluronan-gelatin hydrogel films: A covalent mimic of the extracellular matrix for in vitro cell growth. Biomaterials 2003;24:3825-3834.
27. Lee KY, Mooney DJ. Hydrogels for tissue engineering. Chem Rev 2001;101:1869-1879.
28. Cohn D, Sosnik A, Levy A. Improved reverse thermoresponsive polymeric systems. Biomaterials 2003;24:3707-3714.
29. Lin HR, Sung KC. Carbopol/pluronic phase change solutions for ophthalmic drug delivery. J Control Release 2000;69:379-388.
30. Kim MR, Park TG. Temperature-responsive and degradable hyaluronic acid/pluronic composite hydrogels for controlled release of human growth hormone. J Control Release 2002;80:69-77.
31. Varshney M, Morey TE, Shah DO, Flint JA, Moudgil BM, Seubert CN, Dennis DM. Pluronic microemulsions as nanoreservoirs for extraction of bupivacaine from normal saline. J Am Chem Soc 2004;126:5108-5112.
32. Garry MG, Jackson DL, Geier HE, Southam M, Hargreaves KM. Evaluation of the efficacy of a bioerodible bupivacaine polymer system on antinociception and inflammatory mediator release. Pain 1999;82:49-55.
33. Larsen DB, Parshad H, Fredholt K, Larsen C. Characteristics of drug substances in oily solutions; drug release rate, partitioning and solubility. Int J Pharm 2002;232:107-117.
34. Dollo G, Malinovsky JM, Peron A, Chevanne F, Pinaud M, Le Verge R, Le Corre P. Prolongation of epidural bupivacaine effects with hyaluronic acid in rabbits. Int J Pharm 2004;272:109-119.
35. Jeong B, Kim SW, Bae YH. Thermosensitive sol-gel reversible hydrogels. Adv Drug Deliv Rev 2002;54:37-51.
36. Hwang MJ, Suh JM, Bae YH, Kim SW, Jeong B. Caprolactonic poloxamer analog: PEG-PCL-PEG. Biomacromolecules 2005;6:885-890.
37. Chen PC, Park YJ, Chang LC, Kohane DS, Bartlett RH, Langer R, Yang VC. Injectable microparticle-gel system for prolonged and localized lidocaine release. I. In vitro characterization. J Biomed Mater Res A 2004;70:412-419.
38. Curley J, Castillo J, Hotz J, Uezono M, Hernandez S, Lim JO, Tigner J, Chasin M, Langer R, Berde C. Prolonged regional nerve blockade. Injectable biodegradable bupivacaine/polyester microspheres. Anesthesiology 1996;84:1401-1410.